Protocol for the prevention of ventricular arrhythmiss due to treatment in COVID-19 patients

被引:0
|
作者
Cueva-Parra, Angel [1 ]
Neach-de-la-Vega, Diego [1 ]
Ortiz-Solis, William [1 ]
Fernandez-Domenech, Jose [1 ]
Lara-Aguilera, Selene [1 ]
Chi-Pool, Sandra [1 ]
Munoz-Benavides, Guillermo [1 ]
Bustillos-Garcia, Gabriela A. [1 ]
Marquez-Murillo, Manlio [1 ]
Gomez-Flores, Jorge [1 ]
Levinstein-Jacinto, Moises [1 ]
Mendoza-G, Celso [1 ]
Nava-Townsend, Santiago [1 ]
机构
[1] Inst Nacl Cardiol Ignacio Chavez, Serv Electrofisiol, Ciudad De Mexico, Mexico
来源
关键词
QT INTERVAL PROLONGATION; RISK;
D O I
10.24875/ACM.M20000070
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
COVID-19 is an acute respiratory syndrome caused by coronavirus-2 (SARS C0V2). The different cardiac imaging methods have issued specific recommendations for the different imaging methods in this pandemic, so it is essential to emphasize the recommendations for carrying out these studies. © 2020 Instituto Nacional de Cardiologia Ignacio Chavez. Publicado por Permanyer.
引用
收藏
页码:56 / 61
页数:6
相关论文
共 50 条
  • [41] Practical considerations in prevention and treatment of venous thromboembolism in hospitalized patients with COVID-19
    Smith, Kelly
    Krajewski, Kristin C.
    Krajewski, Michael P., Jr.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2020, 77 (21) : 1739 - 1745
  • [42] Expert Consensus on Prevention and Treatment of COVID-19 Infection in Patients with Lung Cancer
    Non-small Cell Lung Cancer Expert Commitee of Chinese Society of Clinical Oncology
    China Medical Education Association
    中国肺癌杂志, 2023, (03) : 165 - 176
  • [43] Prevention of Scarring of Lung Parenchyma in COVID-19 Patients through Glucocorticoid Treatment
    Bozkurt, Nurgul
    Yalcin, Ata N.
    AMERICAN JOURNAL OF HEALTH BEHAVIOR, 2023, 47 (01): : 182 - 193
  • [44] Treatment and Prevention Strategies for Patients with Gynecological Malignancies During the COVID-19 Pandemic
    Yang, Jiang
    Liu, Jin
    Li, Suting
    Hong, Li
    RISK MANAGEMENT AND HEALTHCARE POLICY, 2020, 13 : 1181 - 1185
  • [45] Modifiable Host Factors for the Prevention and Treatment of COVID-19: Diet and Lifestyle/Diet and Lifestyle Factors in the Prevention of COVID-19
    Hibino, Sawako
    Hayashida, Kazutaka
    NUTRIENTS, 2022, 14 (09)
  • [46] COVID-19 Associated Cardiovascular Disease-Risks, Prevention and Management: Heart at Risk Due to COVID-19
    Kemerley, Andrew
    Gupta, Abhishek
    Thirunavukkarasu, Mahesh
    Maloney, Monica
    Burgwardt, Sean
    Maulik, Nilanjana
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (03) : 1904 - 1920
  • [47] The Idea and Application of Tuina in the Prevention and Treatment of COVID-19
    Zhengyu Li
    ChineseMedicineandCulture, 2020, 3 (03) : 152 - 157
  • [48] Editorial: Neutralizing Antibodies in the Prevention and Treatment of COVID-19
    Razonable, Raymund R.
    Chen, Peter
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] Future developments in the prevention, diagnosis and treatment of COVID-19
    Coltart, Cordelia E. M.
    Collet-Fenson, Luke B.
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2021, 73 : 56 - 80
  • [50] Deployment of convalescent plasma for the prevention and treatment of COVID-19
    Bloch, Evan M.
    Shoham, Shmuel
    Casadevall, Arturo
    Sachals, Bruce S.
    Shaz, Beth
    Winters, Jeffrey L.
    van Buskirk, Camille
    Grossman, Brenda J.
    Joyner, Michael
    Henderson, Jeffrey P.
    Pekosz, Andrew
    Lau, Bryan
    Wesolowski, Amy
    Katz, Louis
    Shan, Hua
    Auwaerter, Paul G.
    Thomas, David
    Sullivan, David J.
    Paneth, Nigel
    Gehrie, Eric
    Spitalnik, Steven
    Hod, Eldad A.
    Pollack, Lewis
    Nicholson, Wayne T.
    Pirofski, Liise-Anne
    Bailey, Jeffrey A.
    Tobian, Aaron A. R.
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (06): : 2757 - 2765